Divalproex Sodium Tablet, Extended Release
Product Images NDC 70518-1556

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-1556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium 250mg 70518 1556 01

Divalproex Sodium Extended-Release 250mg Tablet, quantity of 100, is a prescription medicine manufactured by Amneal Pharma located in Bridgewater, NJ. It is repackaged by RemedyRepack Inc. and comes with a package insert with instructions for use. The tablet should be stored at a temperature between 20-26°C, with occasional excursions up to 15-30°C, and kept out of reach of children. The expiration date and lot number are not available in the given text.*

FDA Label Image

Divalproex Sodium 250mg 70518 1556 02

This is a description of a medication called Divalproex Sodium Extended-Release in the form of a 250 mg tablet. The label includes the prescription requirement, NDC number, LOT number, and the manufacturer's name and location. The package insert contains the directions for use. The medication should be stored between 20-26°C (63-77°F), excursions permitted to 15-30°C (59-86°F) [See USP]. The medication was repackaged by RemedyRepack Inc., Indiana, PA 15701.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a medication named Divalproex Sodium available in form of a 250mg extended-release tablet. It comes in a QTY of 30 HD2 and is repacked by RemedyRepack Inc. It has an NDC code of 70518-1556-00 and should be kept out of reach of children. The package insert should be consulted for directions of usage. It should be stored between 20-26°C (63-77°F) with excursions allowed at 15-30°C (59-86°F) according to USP guidelines. The medication was initially manufactured by Amneal Pharma in Bridgewater, N.J 0880. LOT and expiry details are not available.*

FDA Label Image

10 (Divalproex Sodium Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)

FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)

This appears to be a graph showing the percentage reduction in CPS (probably referring to some medical measure) rate for patients who received either high- or low-dose Divalproex Sodium. The graph shows the improvement, no change, or worsening in the condition of patients receiving the medication. No further information can be obtained from this text.*

FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.